Aplagon

Aptatargets

The company develops aptamer-based therapeutic drugs for patients with acute ischemic stroke and other inflammatory or cardiovascular diseases.

ProCorde AG

This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.

Apoxis SA

This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Versono

This company develops ultrasonic intravascular devices to treat complex arterial blockages for patients suffering from peripheral vascular disease and critical limb ischaemia.

Proteon Therapeutics

This company develops pharmaceuticals to improve blood flow and vascular access for patients with kidney and vascular diseases.

Cyclarity

This biopharmaceutical company develops engineered cyclodextrin molecules to remove arterial plaque and treat age-related vascular diseases for patients with atherosclerosis and heart conditions.

Aortyx

This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.